Suppr超能文献

肿瘤学环境中的神经心理学实践。

Neuropsychological Practice in the Oncology Setting.

作者信息

Noll Kyle R, Bradshaw Mariana E, Rexer Jennie, Wefel Jeffrey S

机构信息

Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Arch Clin Neuropsychol. 2018 May 1;33(3):344-353. doi: 10.1093/arclin/acx131.

Abstract

Oncology has experienced positive shifts in survival curves for many cancers largely due to the development of earlier diagnostics and better therapeutics. This has increased the visibility and need for survivorship services, including clinical neuropsychology. Patients with cancer frequently experience cognitive dysfunction related to the presence of cancer itself and treatment neurotoxicity. These cognitive difficulties can profoundly impact patient functioning and autonomy with accompanying declines in quality of life. Clinical neuropsychologists are uniquely positioned to evaluate the cognitive and affective sequelae of cancer and treatment and provide interventions and recommendations that can benefit well-being and potentially alter the disease course. Despite increasing recognition of the importance of neuropsychological issues to cancer survivorship, many neuropsychologists have limited training and guidance regarding navigating and implementing services within the oncology setting. This article provides the basic rationale for neuropsychological practice and research activities in oncology, as well as the experience of the Section of Neuropsychology at The University of Texas MD Anderson Cancer Center.

摘要

肿瘤学在许多癌症的生存曲线方面取得了积极进展,这主要归功于早期诊断和更好治疗方法的发展。这提高了对包括临床神经心理学在内的生存服务的关注度和需求。癌症患者经常经历与癌症本身的存在以及治疗神经毒性相关的认知功能障碍。这些认知困难会严重影响患者的功能和自主性,同时导致生活质量下降。临床神经心理学家在评估癌症及治疗的认知和情感后遗症方面具有独特优势,并能提供有助于改善健康状况且可能改变疾病进程的干预措施和建议。尽管人们越来越认识到神经心理学问题对癌症幸存者的重要性,但许多神经心理学家在肿瘤学环境中开展和实施服务方面的培训和指导有限。本文提供了肿瘤学中神经心理学实践和研究活动的基本理论依据,以及德克萨斯大学MD安德森癌症中心神经心理学部门的经验。

相似文献

1
Neuropsychological Practice in the Oncology Setting.
Arch Clin Neuropsychol. 2018 May 1;33(3):344-353. doi: 10.1093/arclin/acx131.
2
Cognitive functioning in long-term cancer survivorship: A survey utilizing both standardized neuropsychological and self-report measures.
Appl Neuropsychol Adult. 2019 Mar-Apr;26(2):173-180. doi: 10.1080/23279095.2017.1387551. Epub 2017 Nov 3.
3
Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology.
J Int Neuropsychol Soc. 2014 Feb;20(2):129-34. doi: 10.1017/S1355617714000010. Epub 2014 Feb 4.
4
A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment.
Trends Neurosci. 2018 Aug;41(8):493-496. doi: 10.1016/j.tins.2018.05.001. Epub 2018 Jun 12.
5
Neuropsychological Evaluation for Oncology.
Neurol Clin. 2024 Nov;42(4):875-887. doi: 10.1016/j.ncl.2024.05.012. Epub 2024 Jun 15.
6
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice.
Oncol Res Treat. 2024;47(5):218-223. doi: 10.1159/000538277. Epub 2024 Mar 12.
8
Applying the International Classification of Functioning-Children and Youth Version to Pediatric Neuro-oncology.
J Child Neurol. 2017 Jan;32(1):23-28. doi: 10.1177/0883073816669647. Epub 2016 Oct 6.
10
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer.
Neurosci Biobehav Rev. 2019 Dec;107:602-614. doi: 10.1016/j.neubiorev.2019.09.028. Epub 2019 Sep 22.

引用本文的文献

1
Integrated early palliative care for patients with newly diagnosed glioblastoma: The GLIOSUPPORT feasibility study.
Neurooncol Adv. 2025 Mar 27;7(1):vdaf064. doi: 10.1093/noajnl/vdaf064. eCollection 2025 Jan-Dec.
2
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives.
Neurooncol Adv. 2025 Apr 11;7(1):vdaf072. doi: 10.1093/noajnl/vdaf072. eCollection 2025 Jan-Dec.
4
Neuropsychological Evaluation for Oncology.
Neurol Clin. 2024 Nov;42(4):875-887. doi: 10.1016/j.ncl.2024.05.012. Epub 2024 Jun 15.
5
6
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology.
J Neurooncol. 2023 May;162(3):525-533. doi: 10.1007/s11060-023-04289-4. Epub 2023 Mar 20.
8
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancer.
BJUI Compass. 2022 Aug 24;3(6):424-433. doi: 10.1002/bco2.179. eCollection 2022 Nov.
10
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Nat Rev Neurol. 2022 Mar;18(3):173-185. doi: 10.1038/s41582-021-00617-2. Epub 2022 Feb 9.

本文引用的文献

1
The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.
J Neurooncol. 2017 Feb;131(3):565-574. doi: 10.1007/s11060-016-2328-1. Epub 2016 Nov 15.
3
Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.
Neuro Oncol. 2016 Dec;18(12):1656-1663. doi: 10.1093/neuonc/now165. Epub 2016 Aug 30.
5
Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.
J Clin Oncol. 2016 Jun 1;34(16):1905-12. doi: 10.1200/JCO.2015.64.1969. Epub 2016 Apr 11.
6
Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.
Neuro Oncol. 2016 Mar;18 Suppl 2(Suppl 2):ii13-ii20. doi: 10.1093/neuonc/nov291.
7
Neurocognitive functioning and genetic variation in patients with primary brain tumours.
Lancet Oncol. 2016 Mar;17(3):e97-e108. doi: 10.1016/S1470-2045(15)00380-0. Epub 2016 Mar 2.
8
Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.
J Cancer Surviv. 2016 Jun;10(3):593-9. doi: 10.1007/s11764-015-0505-4. Epub 2015 Dec 12.
10
Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.
Neurosurgery. 2015 Nov;77(5):777-85. doi: 10.1227/NEU.0000000000000987.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验